期刊文献+

恶性疟原虫合子/动合子表面25蛋白自身偶联条件的优化及其聚体蛋白的制备

Optimization of coupling reaction for Pfs25 protein and preparation of relevant conjugation
下载PDF
导出
摘要 目的探讨影响恶性疟原虫合子/动合子表面25蛋白(25 k Da Plasmodium falciparum sexual stage protein,Pfs25)偶联的因素,优化Pfs25蛋白的偶联反应条件,制备具有免疫原性的Pfs25纯化聚体蛋白。方法通过对偶联反应时Pfs25蛋白浓度、偶联反应的酸碱度、不同的缓冲液及偶联试剂添加方式的探索,考察不同反应条件对Pfs25蛋白偶联的影响。凝胶过滤层析纯化Pfs25偶联反应产物,双抗体夹心ELISA和SDS-PAGE对凝胶柱洗脱液进行检测,Western blot检测纯化的Pfs25聚体蛋白。结果 Pfs25蛋白偶联反应选择1/15 mol/L Na_2HPO_4-KH_2PO_4为偶联缓冲液,反应体系在pH 5.6~6.0时偶联效果更好,而Pfs25蛋白反应质量浓度为25 mg/m L时可获得最佳的Pfs25偶联效率(68.67%),凝胶过滤层析法获得Pfs25聚体蛋白,经双抗体夹心ELISA和Western blot检测,形成的Pfs25聚体蛋白保持了与Pfs25蛋白相同的抗体结合能力。结论优化了Pfs25蛋白最佳偶联反应条件,获得具有免疫原性的Pfs25纯化聚体蛋白。在形成Pfs25聚体中,以二聚体(Pfs25)2为主要形式,兼有少量三聚体(Pfs25)3和四聚体(Pfs25)4。 Objective To search for an optimal condition for Pfs25 in the coupling reaction,and to prepare the conjugation of Pfs25. Methods Reaction facters were investigated including,concentration of Pfs25,p H,buffer type and adding mode of the coupling reagent,and the resulted influence in coupling process was evaluated. The conjugation and detection of Pfs25 were carried out by means of gel filtration,SDS-PAGE,double-antibody sandwich ELISA and the Western blot.Results The optimal coupling reaction of Pfs25 included the following factors: buffer was 1/15 mol/L Na2HPO4-KH2PO4,pH 5.6-6.0 and Pfs25 with a concentration of 25 mg/m L. Under these conditions,the best coupling rate( 68.67%)was obtained and the resulted Pfs25 conjugation was kept the same antibody binding capacity for Pfs25. Conclusion The optimal conditions for Pfs25 in the coupling reaction were obtained. As a consequence,Pfs25 conjugation could preserve the original antigenicity,and present in a mixture of polymers including dimer( Pfs25)2,trimer( Pfs25)3 and tetramer( Pfs25)4,and the dimer( Pfs25)2 was the primary type.
作者 李刚 高雪峰 周晖国 陈俏丽 王爱秀 陈勇 LI Gang;GAO Xue-feng;ZHOU Hui-guo;CHEN Qiao-li;WANG Ai-xiu;CHEN Yong(Fourth Department of Research,Lanzhou Institute of Biological Products Co.,Ltd., Center for Gansu Provincial Vaccine Engineering Research,Lanzhou 730046,Gansu Province,China)
出处 《微生物学免疫学进展》 2018年第6期40-45,共6页 Progress In Microbiology and Immunology
基金 2014年甘肃省自然科学基金(145RJZA231)
关键词 Pfs25蛋白质 己二酸二酰肼 乙基二甲基胺丙基碳化二亚胺 偶联 Pfs25 Diacylhydrazine adipate Ethylenedimethylamine propyl carbodiimide Coupling reaction
  • 相关文献

参考文献3

二级参考文献30

  • 1李金明,叶应妩,林其燧.脂质体免疫测定技术[J].国外医学(临床生物化学与检验学分册),1993,14(3):116-120. 被引量:1
  • 2周之鸿 徐宁宁 等.脂质体中磷脂的含磷量测定[J].药学通报,1987,2:77-77.
  • 3WHO. World Malaria Report 2009[EB/OL]. http://www.who.int/malaria/world_alaria_report_2009 /en/index.html.
  • 4Kaslow D C, Quakyi I A, Syin C, et al. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains[J]. Nature, 1988,333(6168):74-76.
  • 5Barr P J, Green K M, Gibson H L, et al. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission- blocking immunity in experimental animals [J]. J Exp Med, 1991,174(5):1203-1208.
  • 6Zou L, Miles A P, Wang J, et al. Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials[J]. Vaccine, 2003,21(15):1650- 1657.
  • 7Wu Y, Ellis R D, Shaffer D, et al. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51[J]. PloS one, 2008,3(7):e2636.
  • 8Singh M B, Bhalla P L. Recombinant expression systems for allergen vaccines[J]. Inflamm Allergy Drug Targets, 2006,5(1): 53-59.
  • 9Waterham H R, Digan M E, Koutz P J, et al. Isolation of the Pichia pastoris glyceraldehyde-3-phosphate dehydrogenase gene and regulation and use of its promoter[J]. Gene, 1997,186(1): 37-44.
  • 10Vassileva A, Chugh D A, Swaminathan S, et al. Expression of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris using the GAP promoter[J]. J Biotechnol, 2001,88(1): 21-35.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部